About Medicsight

Medicsight Ltd is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerised tomography (CT) scans of the colon and lung, helping radiologists to identify, measure, and analyse potential disease and early indicators of disease. Medicsight's CAD software has been developed using a large and population diverse database of verified patient CT scan data. Medicsight's ColonCAD™ and LungCAD™ software products are seamlessly integrated with the advanced 3D visualisation workstations of several industry-leading imaging equipment partners.

MGT Capital Investments, Inc. currently has a controlling interest in Medicsight Ltd. Medicsight and its wholly owned subsidiaries is a medical technology company focusing on medical imaging software development and medical hardware devices. The investor pages that follow are your resource for financial information about MGT Capital Investments, Inc. In this section you will find information about our current and historical share price, press releases, management, corporate governance, SEC filings, an electronic version of our annual report and frequently asked questions, as well as forms to request additional information.

www.mgtci.com